Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | PRKDC | P78527 | 1/20 | 0.42 |
| ▸ | TNKS | O95271 | 2/20 | 0.41 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.41 |
| ▸ | NSD2 | O96028 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17448503 | 0.80 | NQO1 (0.50) | NQO1CA1CA2CA7CA9 | |
| SCHEMBL5950717 | 0.79 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL28016714 | 0.79 | CA2 (0.47) | NQO1CA1CA2CA7CA9 | |
| SCHEMBL357145 | 0.78 | CA1 (0.61) | NQO1CA1CA2CA7CA9 | |
| SCHEMBL31116611 | 0.78 | CA1 (0.61) | NQO1CA1CA2CA7CA9 | |
| SCHEMBL30952013 | 0.78 | NQO1 (0.48) | NQO1CA1CA2CA7CA9 | |
| SCHEMBL1501174 | 0.76 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL5759879 | 0.76 | IDO1 (0.47) | NQO1CA1CA2CA7CA9 | |
| SCHEMBL3179355 | 0.75 | NQO1 (0.67) | NQO1CA1CA2CA7CA9 | |
| SCHEMBL17447192 | 0.75 | HDAC4 (0.46) | NQO1CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2470543-B1 | VISIBLE/NIR PHOTODETECTORS | UNIV MICHIGAN REGENTS (US) | 2017-07-26 | — | — | EP | disclosed |
| US-20150318479-A1 | Visible/Near-Infrared Porphyrin-Tape/C60 Organic Photodetectors | UNIVERSITY OF SOUTHERN CALIFORNIA | 2015-11-05 | — | — | US | disclosed |
| US-9017826-B2 | Visible/near-infrared porphyrin-tape/C60 organic photodetectors | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2015-04-28 | — | — | US | disclosed |
| EP-2470543-A1 | VISIBLE/NIR PHOTODETECTORS | The Regents of the University of Michigan (US) | 2012-07-04 | — | — | EP | disclosed |
| US-20110168984-A1 | VISIBLE/NEAR-INFRARED PORPHYRIN-TAPE/C60 ORGANICPHOTODETECTORS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-07-14 | — | — | US | disclosed |
| WO-2011028610-A1 | VISIBLE/NIR PHOTODETECTORS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150318479-A1 | Visible/Near-Infrared Porphyrin-Tape/C60 Organic Photodetectors | PAH, PPOX, AHR | NQO1 2479/4885CA1 3400/4885CA2 4039/4885 |
| US-20110168984-A1 | VISIBLE/NEAR-INFRARED PORPHYRIN-TAPE/C60 ORGANICPHOTODETECTORS | PAH, PPOX, AHR | NQO1 2294/4885CA1 3193/4885CA2 4036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.